Loading...
NAYA Biosciences, Inc. Common Stock
IVF•NASDAQ
Healthcare
Medical - Healthcare Plans
$2.24
$0.05(2.28%)
NAYA Biosciences, Inc. Common Stock (IVF) Financial Performance & Income Statement Overview
Review NAYA Biosciences, Inc. Common Stock’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
116.25%
↑ 116.25%
Operating Income Growth
-20.07%
↓ 20.07%
Net Income Growth
-13.21%
↓ 13.21%
Operating Cash Flow Growth
37.45%
↑ 37.45%
Operating Margin
-368.37%
↓ 368.37%
Gross Margin
41.57%
↑ 41.57%
Net Profit Margin
-377.72%
↓ 377.72%
ROE
-571.72%
↓ 571.72%
ROIC
-186.46%
↓ 186.46%
NAYA Biosciences, Inc. Common Stock (IVF) Income Statement & Financial Overview
Review NAYA Biosciences, Inc. Common Stock's (IVF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.69M | $1.43M | $1.84M | $1.58M |
| Cost of Revenue | $957419.00 | $988465.00 | $861648.00 | $850234.00 |
| Gross Profit | $728547.00 | $444686.00 | $974949.00 | $726052.00 |
| Gross Profit Ratio | $0.43 | $0.31 | $0.53 | $0.46 |
| R&D Expenses | $484780.00 | $0.00 | $0.00 | $4880.00 |
| SG&A Expenses | $3.48M | $1.51M | $2.65M | $1.44M |
| Operating Expenses | $4.70M | $1.75M | $2.88M | $1.67M |
| Total Costs & Expenses | $5.66M | $2.73M | $3.74M | $2.52M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $231824.00 | $273629.00 | $369612.00 | $181295.00 |
| Depreciation & Amortization | $231810.00 | $230495.00 | $230338.00 | $226960.00 |
| EBITDA | -$3.21M | -$1.10M | -$1.65M | -$1.19M |
| EBITDA Ratio | -$1.91 | -$0.77 | -$0.90 | -$0.75 |
| Operating Income | -$3.98M | -$1.30M | -$1.90M | -$946374.00 |
| Operating Income Ratio | -$2.36 | -$0.91 | -$1.04 | -$0.60 |
| Other Income/Expenses (Net) | $298306.00 | -$301001.00 | -$342257.00 | -$648303.00 |
| Income Before Tax | -$3.68M | -$1.60M | -$2.25M | -$1.59M |
| Income Before Tax Ratio | -$2.18 | -$1.12 | -$1.22 | -$1.01 |
| Income Tax Expense | -$54008.00 | $29259.00 | $0.00 | $1836.00 |
| Net Income | -$3.62M | -$1.63M | -$2.25M | -$1.60M |
| Net Income Ratio | -$2.15 | -$1.14 | -$1.22 | -$1.01 |
| EPS | -$9.04 | -$5.04 | -$7.44 | -$5.04 |
| Diluted EPS | -$9.04 | -$5.04 | -$7.44 | -$5.04 |
| Weighted Avg Shares Outstanding | $401011.00 | $323832.00 | $300817.00 | $316823.00 |
| Weighted Avg Shares Outstanding (Diluted) | $401011.00 | $323832.00 | $300817.00 | $316823.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan